Bipolar Disorder
APA Comments on FDA's First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
Published in Healthcare Mergers, Acquisitions and Ventures Week, September 8th, 2007
The American Psychiatric Association (APA) applauds the U.S. Food and Drug Administration (FDA) for its review of scientific evidence that led to the approval of a new treatment for two severe psychiatric disorders in children. The APA is pleased that the approvals are a result of the federal Best Pharmaceuticals for Children Act (BCPA), which was designed to encourage research that leads to this kind of approval, given that dosages, side effects and efficacy can vary significantly with children.
"Schizophrenia and bipolar disorder are severely disabling to patients and devastating to their families," said APA President Carolyn Robinowitz, M.D. "For many children...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Aarp
AARP Statement on the Iowa Democratic Debate on ABC's 'This Week with George Stephanopoulos' - Access Innovations, Inc.
Access Innovations Instrumental in Updating RevolutionHealth.com - Acne Vulgaris
ThermaClear Adds Some Heat to the Cool New Offerings at HSN - Acne Vulgaris
Zeno Participates in Teen Choice Awards - Acne Vulgaris Prevention
New acne vulgaris prevention study results from Hill Top Research described - Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics Ranked in Top 10 of Deloitte's Technology Fast 50 Program for New Jersey - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
